Both in Pharmaceuticals
ProMIS Neurosciences Inc. Common Shares (ON) vs Lite Strategy
Over the past year PMN returned −67.8% and LITS returned −41.7%; their daily moves had a correlation of 0.12.
PMN −67.8% LITS −41.7%Growth of $1, one year, split-adjusted
| Metric | PMN | LITS |
|---|---|---|
| Price | $3.31 | $1.12 |
| Market cap | $29.7M | $34.1M |
| Today | −70.13% | −4.27% |
| 1 month | −64.7% | −18.5% |
| 6 months | −69.9% | −0.9% |
| Year to date | −51.5% | −15.2% |
| 1 year | −68.2% | −46.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $53.5M | $5.7M |
| Dividend yield | — | — |
| Volatility (60d) | 261.0% | 79.6% |
| Short % of float | 3.3% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).